Medicare AdvantageAdministrativeMedium impact
Polypharmacy Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH) and Concurrent Use of Opioids and Benzodiazepines (COB)
Horizon BCBS NJ·Geriatrics, Family Medicine, Internal Medicine +3 more·Provider News
We identified it
Jun 26, 2026
Summary
This is a policy announcement from Horizon Blue (December 2024) introducing clinical guidelines and monitoring initiatives for polypharmacy involving multiple anticholinergic medications in older adults (Poly-ACH) and concurrent use of opioids and benzodiazepines (COB). The policy emphasizes primary care coordination, patient engagement, and compliance tracking but does not specify immediate billing changes or prior authorization requirements in the provided content.
Action Required
Billing and clinical teams should: (1) Monitor Horizon Blue communications for specific implementation guidance on Poly-ACH and COB monitoring policies; (2) Prepare providers to document clinical rationale for polypharmacy cases involving anticholinergic medications and concurrent opioid-benzodiazepine use; (3) Ensure EMR templates include screening for these drug combination risks, particularly for Medicare Advantage members; (4) Track any future policy updates from Horizon Blue that may include prior authorization requirements or billing code changes. No immediate deadline specified, but anticipate potential prior authorization requirements or billing impact as implementation guidance is released.